References
- Morokuma K, Kobori N, Fukuda T, et al. Experimental manufacture of equine antivenom against Yamakagashi (Rhabdophis tigrinus). Jpn J Infect Dis. 2011;64:397–402.
- Hifumi T, Yamamoto A, Morokuma K, et al. Surveillance of the clinical use of mamushi (Gloydius blomhoffii) antivenom in tertiary care centers in Japan. Jpn J Infect Dis. 2011;64:373–376.
- Hifumi T, Sakai A, Yamamoto A, et al. Clinical characteristics of Yamakagashi (Rhabdophis tigrinus) bites: a national survey in Japan, 2000–2013. J Intensive Care. 2014;2:19.
- Hifumi T, Sakai A, Yamamoto A, et al. Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites. J Intensive Care. 2014;2(1):44
- Gando S, Iba T, Eguchi Y, et al. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group: a multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625–631.
- Kawano N, Kuriyama T, Yoshida S, et al. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution. Intern Med. 2013;52:55–62. Epub 2013 Jan 1.
- Hifumi T, Murakawa M, Sakai A, et al. Potentially fatal coagulopathy secondary to Yamakagashi (Rhabdophis tigrinus) bites that completely recovered with antivenom treatment. Acute Med Surg. 2015;2:123–126.
- Hifumi T, Sakai A, Kondo Y, et al. Venomous snake bites: clinical diagnosis and treatment. J Intensive Care. 2015;13:16.
- Weinstein SA, White J, Keyler DE, et al. Non-front-fanged colubroid snakes: a current evidence-based analysis of medical significance. Toxicon. 2013;69:103–113. doi: 10.1016/j.toxicon.2013.02.003. Epub 2013 Feb 24.
- Komuro R, Ikeda E, Tokugawa T, et al. A case of DIC due to snake (Rhabdophis tigrinus) bite. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc). 1998;59:253–258. [Japanese].
- Kawamura Y, Sakai A, Sawai Y. Studies of the pathogenesis of envenomation of the Japanese colubrid snake, Yamakagashi, Rhabdophis tigrinus (BOIE). 3. Preparation of anti-Yamakagashi antivenom. Snake 1986:18:4–5.
- Sakai A, Honma M, Sawai Y. Studies on the pathogenesis of envenomation of the Japanese colubrid snake, Yamakagashi, Rhabdophis tigrinus (BOIE). Snake. 1983;15:7–13.
- Isbister GK. Snakebite doesn’t cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost. 2010;36:444–451. Epub 2010 Jul 7
- Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001;37:181–188. Feb Review.
- Sakai A, Moriguchi H, Toriba M. Guide of venomous snake bites for field workers. Bull Herpetol Soc Jpn. 2002;2002:275–292.
- Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA. 1981;78:2249–2252. Apr